Kidney Disease
Conditions
Interventions
Pharmaceutical Care
Usual Care
Sponsors
Akinola Alexander A
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Patients =18 years diagnosed with CKD stages 3 and 4 • CKD related to hypertension and diabetes. • Outpatients who have been attending the renal clinic > 6 months • CKD patients with uncontrolled BP =140/90mmHg • Patients willing and able to give informed consent to participate in the study
Exclusion criteria
Exclusion criteria: • Inpatients, dialysis, ESRD (Stage 5), Post renal transplant patients • unable or unwilling to provide consent • institutionalized (e.g. prisoner, nursing home resident or skilled nursing facility resident) • Pregnant or breast-feeding women • Currently participating in an interventional clinical trial or in a research study that adds significantly to the participant’s burden • Currently diagnosed with Acute kidney Injury, Nephrotic disease, Impaired mental status, Lupus, Sickle Cell Disease, Polycystic Kidney Disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean change in systolic blood pressure (SBP) of patients with CKD from baseline to 6 months of follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mean change in eGFR and UACR values from baseline to 6 months of follow-up. 2. Mean change in diastolic blood pressure from baseline to 6 months of follow-up. 3. Mean change in HRQoL domains from baseline to 6months of follow-up | — |
Countries
Nigeria
Contacts
Public ContactAlexander Akinola
Lecturer II UNILAG
Outcome results
None listed